Company intelligence / Profile preview

Citoxlab

Ownership: Private
Employees: ~800
Development stage: Other

Overview

Citoxlab was a leading global contract research organization providing comprehensive preclinical and specialty safety evaluation services to pharmaceutical, biotechnology, chemical and medical device companies. Its expertise included toxicology, pharmacokinetics/DMPK/ADME studies, bioanalysis, immunology and safety pharmacology. In April 2019 it was acquired by Charles River Laboratories.

Modalities: Small moleculeBiologicMedical device (testing services)Vaccine (testing services)Peptides (testing services)
Industry: Contract Research Organization

Partnerships

AtlanbioStemina Biomarker Discovery

Beyond the preview

Go deeper on Citoxlab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Citoxlab.

Explore the full profile